Neuronetics, Inc. Shareholders' Equity
Neuronetics, Inc. (STIM) had Shareholders' Equity of $17.85 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $17.85M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $13.27M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $22.38M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $27.36M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $17.85M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $13.27M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $22.38M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $27.36M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $27.15M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $35.45M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $27.71M 10-K · filed 2026-03-17 | |
| 2024-09-30 | -$136.92M 8-K/A · filed 2025-02-06 | $9.38M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $19.39M 10-Q · filed 2024-11-12 | |
| 2024-03-31 | $27.66M 10-Q · filed 2024-11-12 | |
| 2023-12-31 | $34.19M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $37.94M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $45.48M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $48.34M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $57.06M 10-Q · filed 2024-11-12 | |
| 2022-09-30 | $62.99M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $68.42M 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $76.60M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $85.17M 10-K · filed 2024-03-08 | |
| 2021-09-30 | $91.08M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $97.17M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $101.97M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $25.49M 10-K · filed 2024-03-08 | |
| 2020-09-30 | $27.48M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $29.44M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $36.51M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $47.85M 10-K · filed 2023-03-07 | |
| 2019-09-30 | $54.33M 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $59.82M 10-Q · filed 2020-11-02 | |
| 2019-03-31 | $65.42M 10-Q · filed 2020-11-02 | |
| 2018-12-31 | $71.04M 10-K · filed 2022-03-08 | |
| 2018-09-30 | $76.35M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | -$205.27M 10-Q · filed 2019-11-05 | |
| 2018-03-31 | -$197.97M 10-Q · filed 2019-11-05 | |
| 2017-12-31 | -$192.65M 10-K · filed 2021-03-02 | |
| 2016-12-31 | -$177.12M 10-K · filed 2020-03-03 | |
| 2015-12-31 | -$166.12M 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |